FindTrial
Sign In

A Observational Study to understand the Effectiveness and Tolerability of Azithromycin on Patients with Upper Respiratory Tract Infection.

Assessment of CliniCal Efficacy and Safety of Azithromycin in PharyngiTis ACCEPT - ACCEPT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066497
Enrollment
1000
Registered
2024-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J029- Acute pharyngitis, unspecified

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil Control Intervention2: Nil: Nil

Sponsors

Alembic Pharmaceuticals Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients aged more than or equal to 18 years of either gender 2. Patients who had received oral Azithromycin for the management of pharyngitis in the past.

Exclusion criteria

Exclusion criteria: Patients those who were not suitable to receive Azithromycin tablet in management of Pharyngitis as per the local prescription data

Design outcomes

Primary

MeasureTime frame
Proportion of Patient achieving clinical cure (Clinical cure is defined as complete resolution of clinical sign & symptoms of pharyngitis)Timepoint: From baseline till 5th day after treatment initiation—

Secondary

MeasureTime frame
Proportion of patients having treatment related side-effects on day 3 and day 5Timepoint: Day 3 and Day 5 after treatment initiation—

Countries

India

Contacts

Public ContactDr Dinesh Patil MBBS MD

Alembic Pharmaceuticals Limited

dinesh.patil@alembic.co.in9823953957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026